MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10528-024-10819-0

Медицинская библиотека · Biochemical genetics · 2024

miR-3653-3p Expression in PBMCs: Unveiling the Diagnostic Potential for Ovarian Cancer.

Delek Fatma Seher Pektopal, Tunçer Şeref Buğra, Ödemiş Demet Akdeniz, Erciyas Seda Kılıç, Erdoğan Özge Şükrüoğlu, Saip Pınar, Yazıcı Hülya

СтатьяПеревод в очереди

Аннотация

Ovarian cancer is typically diagnosed at an advanced stage, recurs early and often, and currently lacks effective treatment. Therefore, overall survival and progression-free survival are relatively short for this disease. Sensitive and specific biomarkers for early diagnosis and follow-up for effective treatment of the disease are currently lacking. MicroRNA (miRNA/miR) expression studies are widely used in cancer research. Disruption or malfunction of miRNAs, a class of noncoding small RNAs, has been implicated in cancer progression in several publications. Of note, the expression of a series of miRNAs is known to differ in ovarian cancer. In cancer research, it is crucial to analyze expression patterns in both cancer patients and healthy individuals to identify cancer-specific biological markers and to understand their role in cancer. In the present study, the expression levels of miR-3653-3p in the peripheral blood mononuclear cells (PBMCs) of 150 patients with high-risk ovarian cancer were determined, including those with a family history of cancer or an early-age diagnosis of ovarian cancer, as well as 100 healthy individuals. The results were then compared between the two groups. The expression level of miR-3653-3p in the PBMCs of patients with ovarian cancer was determined to be 9.49-fold higher than that in the healthy control group, and this result was statistically significant (P < 0.001). In addition, receiver-operating characteristic curve analysis of PBMC showed statistical significance of miR-3653-3p in discriminating ovarian cancer patients from healthy subjects (P < 0.001). These results suggest that miR-3653-3p detected in peripheral blood may be used as a non-invasive biomarker for ovarian cancer.

Для цитирования: Delek Fatma Seher Pektopal, Tunçer Şeref Buğra, Ödemiş Demet Akdeniz, Erciyas Seda Kılıç, Erdoğan Özge Şükrüoğlu, Saip Pınar, Yazıcı Hülya. miR-3653-3p Expression in PBMCs: Unveiling the Diagnostic Potential for Ovarian Cancer.. Biochemical genetics. 2024. DOI: 10.1007/s10528-024-10819-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.